Thyrotropin Over-suppression and Heart
NCT02645786 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2016-01-05
Summary
The investigators evaluated the cardiac effects of Thyroid-stimulating hormone (TSH) over-suppression in women with differentiated thyroid cancer (DTC) frequently encountered during suppression therapy.
Conditions
- Malignant Neoplasm of Thyroid
- Heart Diseases
- Thyrotoxicosis on Thyroxine Therapy
Sponsors & Collaborators
-
Chuncheon Sacred Heart Hospital
lead OTHER
Eligibility
- Min Age
- 32 Years
- Max Age
- 51 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2013-11-30
- Completion
- 2014-04-30
More Related Trials
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery
NCT06660823 ·Status: COMPLETED ·Phase: PHASE3
-
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery
NCT02548715 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
NCT00604318 ·Status: COMPLETED ·Phase: PHASE4
-
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
NCT02567877 ·Status: TERMINATED
-
Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation
NCT02824016 ·Status: COMPLETED ·Phase: NA
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED
-
Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma
NCT02689609 ·Status: COMPLETED
-
Central Hypothyroidism and Cardiovascular Risk
NCT01574859 ·Status: COMPLETED
-
Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer
NCT01341886 ·Status: COMPLETED ·Phase: NA
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
NCT05247476 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
NCT01403324 ·Status: TERMINATED ·Phase: NA
-
COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer
NCT06790589 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism
NCT01660126 ·Status: COMPLETED ·Phase: PHASE4
-
Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma
NCT02665325 ·Status: UNKNOWN
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Novel Approaches to the Treatment of Hypothyroidism
NCT06731764 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
NCT04964284 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
NCT01831869 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
NCT00196729 ·Status: COMPLETED ·Phase: PHASE3
-
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 ·Status: RECRUITING ·Phase: NA
-
The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
NCT01384786 ·Status: COMPLETED
-
Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
NCT02512978 ·Status: UNKNOWN ·Phase: PHASE4